Concepedia

Natarajan Ranganathan

NR

9

Publications

1K

Citations

9

H-Index

2005

Active since

Affiliations

Kibow Biotech (United States)(Current)

SUNY Downstate Health Sciences University

University of Toronto

State University of New York

Thomas Jefferson University

Natarajan Ranganathan is an author at Kibow Biotech (United States) specializing in probiotics, medicine, and microbiome.

Top concepts

Publications per year

2005–2022

9

Publications

9

Probiotics, Prebiotics, and Synbiotics: Gut and Beyond

Usha Vyas, Natarajan Ranganathan · Gastroenterology Research and Practice · 2012 · 245 citations · Full text

, , +13

Pilot study of probiotic dietary supplementation for promoting healthy kidney function in patients with chronic kidney disease

Natarajan Ranganathan, Pari Ranganathan, Eli A. Friedman et al. · Advances in Therapy · 2010 · 226 citations

, , +8

Randomized Controlled Trial of Strain-Specific Probiotic Formulation (Renadyl) in Dialysis Patients

Natarajan Ranganathan, Bohdan Pechenyak, Usha Vyas et al. · BioMed Research International · 2014 · 144 citations · Full text

Probiotic dietary supplementation in patients with stage 3 and 4 chronic kidney disease: a 6-month pilot scale trial in Canada

Natarajan Ranganathan, Eli A. Friedman, Paul Tam et al. · Current Medical Research and Opinion · 2009 · 132 citations

Probiotic supplements prevented oxonic acid-induced hyperuricemia and renal damage

Fernando E. García‐Arroyo, Guillermo Gonzaga, Itzel Muñoz-Jiménez et al. · PLoS ONE · 2018 · 91 citations · Full text

, , +16

Rows per page

1–5 of 9